C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training

Claudio Passino1, Silvia Del Ry, Silvia Severino

  • 1Cardiovascular Medicine Department, CNR Institute of Clinical Physiology, Pisa, Italy. passino@ifc.cnr.it

Insights

Aerobic exercise training in heart failure (HF) patients improves physical function and reduces C-type natriuretic peptide (CNP) and B-type natriuretic peptide (BNP) levels, suggesting enhanced endothelial function.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Endocrinology

Background:

  • C-type natriuretic peptide (CNP) is an endothelium-derived hyperpolarizing factor.
  • Endothelial dysfunction is prevalent in chronic heart failure (HF).
  • Physical training can positively impact endothelial function in HF patients.

Purpose of the Study:

  • To investigate the effect of aerobic physical training on CNP expression in HF patients.
  • To assess the relationship between CNP levels and clinical/functional parameters after training.

Main Methods:

  • 90 HF patients were randomized into a control group (19) or an aerobic exercise-training group (71).
  • Intervention involved a 9-month home-based aerobic exercise program.
  • Measurements included plasma CNP, B-type natriuretic peptide (BNP), norepinephrine, echocardiogram, and cardiopulmonary-stress test.

Main Results:

  • Trained patients showed improved peak oxygen uptake (VO2) and ejection fraction.
  • Aerobic training led to decreased plasma levels of norepinephrine, BNP, and CNP.
  • The reduction in CNP correlated with increased peak VO2, and the CNP-BNP relationship was maintained.

Conclusions:

  • Physical training in HF patients improves clinical and functional status.
  • This improvement is linked to reduced adrenergic activation and lower CNP and BNP concentrations.
  • Decreased CNP plasma levels post-training may indicate improved endothelial function.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be met...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...